Private Placement

A medical device firm is delegating its $163M Solana treasury, partnering with The Tie to forge a new path for institutional crypto adoption.

With promising preclinical data and Australian trial approval, Kivu’s KIVU-305 aims to overcome past failures in targeting aggressive solid tumors.

With its stock lagging, TScan Therapeutics will use a key conference to highlight upcoming clinical trial data and convince investors of its pipeline's value.

A new tech startup is launching an AI platform to replace high-pressure sales with transparent pricing, promising to cut homeowners' roof costs by up to 50%.

With major partnerships and a fresh $130M, Solid Power is scaling up solid-state battery tech. But can it overcome key engineering and financial hurdles?

Novo Resources lands a C$5.8M capital injection to accelerate its high-potential gold exploration in the Pilbara and Victoria's Bendigo Zone.

Groundbreaking research shows AI's information diet is dangerously imbalanced, creating an unseen force that could manipulate public opinion and erode democracy.

The Raine Group hires Credit Suisse veteran Anthony Kontoleon, signaling a major push to dominate TMT advisory ahead of an anticipated tech boom.

Amid fluctuating NCLEX pass rates, UWorld launches an intensive three-day review designed to boost student success and ease the burden on nursing faculty.

Tradewinds Universal aims to consolidate the fragmented $8B adult club scene with Peppermint Hippo, but regulatory hurdles and market risks loom large.

With a record EU investment, Axelera AI challenges AI's energy crisis with power-efficient edge chips, aiming for global leadership and digital sovereignty.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

Lithium developer Stardust Power partners with a Pentagon-aligned group, a critical move to reduce foreign reliance and fuel the U.S. energy transition.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

Eminent Gold to detail recent high-grade drill results from its Hot Springs Range Project in a live investor deep-dive with its proven leadership team.

Caidya appoints veteran Michael Clay as COO, leveraging his deep Asia-Pacific expertise to scale operations and solidify its position in the CRO market.

Shareholders approve a major private placement, injecting strategic capital from La Mancha to advance Brazil's controversial Volta Grande Gold Project.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

A massive $12 billion data center investment from Amazon and STACK Infrastructure promises economic renewal for northwest Louisiana, but raises critical questions.